Quantification of intracellular homocysteine by stable isotope dilution liquid chromatography/tandem mass spectrometry

被引:21
作者
Huang, Yuehua
Lu, Zhi-Yong
Brown, Karen S.
Whitehead, Alexander S.
Blair, Ian A.
机构
[1] Univ Penn, Sch Med, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Pharmacogenet, Philadelphia, PA 19104 USA
关键词
intracellular homocysteine; mass spectrometry; LC/MS/MS; stable isotope; folate;
D O I
10.1002/bmc.735
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A precise and accurate stable isotope dilution liquid chromatography/tandem mass spectrometry method for the analysis of intracellular homocysteine has been developed. An internal standard, [H-2(8)]-homocystine, was added to cell pellets from EA.hy 926 cells grown in culture under low and high folate concentrations. D,L-dithiothreitol was used to reduce cellular homocystine to homocysteine. Cellular proteins were precipitated by the addition of formic acid in acetonitrile. After centrifugation. a portion of the supernatant was analyzed by liquid chromatography/tandem mass spectrometry. Using a Supelcosil cyano, column with an Applied Biosystems API 4000 triple quadrupole mass spectrometer, the SRM transitions for homocysteine (m/z 136 to m/z 90) and [H-2(4)]-homocysteine (m/z 140 to m/z 94) were monitored. The method was validated by conducting five replicate analyses on three different days at four different concentrations (concentrations at the lower limit of quantitation and expected lower quartile, mid-range and upper quartile). The limit of detection was 2 ng/10(6) EA.hy 926 cells. Using this method. the intracellular homocysteine concentration in EA.hy 926 cells ranged from 10 to 36 ng/10(6) cells. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 26 条
[1]   Metabolism of homocysteine and its relationship with cardiovascular disease [J].
Aguilar, B ;
Rojas, JC ;
Collados, MT .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2004, 18 (02) :75-87
[2]   Genetic evidence that nitric oxide modulates homocysteine -: The NOS3 894TT genotype is a risk factor for hyperhomocystenemia [J].
Brown, KS ;
Kluijtmans, LAJ ;
Young, IS ;
Woodside, J ;
Yarnell, JWG ;
McMaster, D ;
Murray, L ;
Evans, AE ;
Boreham, CA ;
McNulty, H ;
Strain, JJ ;
Mitchell, LE ;
Whitehead, AS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (06) :1014-1020
[3]  
BROWN KS, 2006, IN PRESS ATHROS 0207, DOI DOI 10.1016/J.ATHERSCLEROSIS.2005.12.018
[4]   Methods for homocysteine analysis and biological relevance of the results [J].
Ducros, V ;
Demuth, K ;
Sauvant, MP ;
Quillard, M ;
Caussé, E ;
Candito, M ;
Read, MH ;
Drai, J ;
Garcia, I ;
Gerhardt, MF .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 781 (1-2) :207-226
[5]   Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence [J].
Eikelboom, JW ;
Lonn, E ;
Genest, J ;
Hankey, G ;
Yusuf, S .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (05) :363-375
[6]  
Fowler Brian, 2005, Semin Vasc Med, V5, P77
[7]   Enzymatic determination of homocysteine in cell extracts [J].
Fu, TF ;
di Salvo, M ;
Schirch, V .
ANALYTICAL BIOCHEMISTRY, 2001, 290 (02) :359-365
[8]   The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations [J].
Gaughan, DJ ;
Kluijtmans, LAJ ;
Barbaux, S ;
McMaster, D ;
Young, IS ;
Yarnell, JWG ;
Evans, A ;
Whitehead, AS .
ATHEROSCLEROSIS, 2001, 157 (02) :451-456
[9]   The role of genetic factors in the development of hyperhomocysteinemia [J].
Geisel, J ;
Hübner, U ;
Bodis, M ;
Schorr, H ;
Knapp, JP ;
Obeid, R ;
Herrmann, W .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (11) :1427-1434
[10]  
Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396